Adaptive and Individualized AAC

• ClinicalTrials.gov Identifier: NCT04247828
• Recruitment Status: Completed
• First Posted: January 30, 2020
• Results First Posted: April 6, 2022
• Last Update Posted: April 6, 2022
• Sponsor: Altec Inc.
• Collaborator: Madonna Rehabilitation Hospital
• Information provided by (Responsible Party): Altec Inc.

Study Description

Brief Summary:

This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.

Condition or disease	Intervention/treatment	Phase
Communication Disorders	Device: Experimental AAC; Device: Generic AAC	Not Applicable

Detailed Description:

The diversity of the more than 1.3% of Americans who suffer from severe physical impairments (SPIs) preclude the use of common augmentative or alternative communication (AAC) solutions such as manual signs, gestures or interaction with a touchscreen for communication. This clinical trial will test the feasibility of developing a smart-AAC system designed using individually adaptive access methods and AAC interfaces to accommodate the unique manifestations of motor impairments specific to each user. The investigators will demonstrate the proof-of-concept that a single surface electromyographic (sEMG) and inertial measurement unit (IMU) hybrid sensor worn on the forehead can provide improvements in information transfer rate (ITR) and communication accuracy when integrated with an AAC interface that is optimized compared to a conventional (non-adaptable) interface for subjects with SPI.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 30 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Adaptive and Individualized AAC
• Actual Study Start Date: January 6, 2020
• Actual Primary Completion Date: August 31, 2021
• Actual Study Completion Date: August 31, 2021

Arms and Interventions

Arm

Intervention/treatment

Experimental: Experimental and Generic Communication Interfaces for AAC; Receives both Experimental and Generic AAC systems to communicate. Each participant will receive both devices, with Experimental AAC presented first (Day 1) and Generic AAC presented second (Day 2; reference).

Device: Experimental AAC; Participant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with an adaptive and individualized keyboard to test communication performance.; Device: Generic AAC; Participant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with a generic QWERTY keyboard to test communication performance.

Outcome Measures

Primary Outcome Measures :

1. Movement Time [ Time Frame: 1 Day ]
   Time needed to navigate a cursor to and select a target on a computer screen by control of head movement and facial muscle contractions for each AAC device, wherein lower movement times equate to better performance.
2. Path-to-Target Movement Variability [ Time Frame: 1 Day ]
   Path smoothness relative to the optimal, straight path between targets on a computer screen by control of head movement and facial muscle contractions for each AAC device. Variability is estimated as a distance of pixels as estimated from a computer screen operating with a resolution of 1920 pixels x 1080 pixels, wherein smaller variability scores equate to better performance.
3. Target Selection Accuracy [ Time Frame: 1 Day ]
   Percentage of accurate selections of targets on a computer screen by control of head movement and facial muscle contractions for each AAC device, wherein higher accuracy scores equate to better performance.
4. Information Transfer Rate [ Time Frame: 1 Day ]
   Human motor performance relative to the speed and accuracy of cursor-to-target movements on a computer screen by control of head movement and facial muscle contractions for each AAC device, wherein higher information transfer rates equate to better performance.
5. AAC Device Usability [ Time Frame: 1 Day ]
   Self-report of perceived AAC device usability as captured via a Likert scale anchored from 1 ("very difficult") to 7 ("very easy"), wherein higher usability scores equate to better performance.

Eligibility Criteria

• Ages Eligible for Study: 12 Years and older (Child, Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

Control Subjects:

• Adults and Children; >12yo
• Male or Female
• All participants will be: (a) able to spell, (b) able to follow 2-3 step directions, (c) have functional vision sufficient to read 40 point text
• No history of communication disorders;
• No history of neurological disorders affecting speech or head movement.

Subjects with SPI:

• Adults or Children; age>12yo
• Male or Female
• All participants will be: (a) able to spell, (b) able to follow 2-3 step directions, (c) have functional vision sufficient to read 40 point text, and (d) have a motor impairment that requires the use of an alternative access strategy to communicate and/or use technology.
• Current or prospective AAC user with complex communication needs representing a broad spectrum of developmental and acquired SPI disabilities resulting from high spinal cord injury, chronic Guillain-Barré syndrome, brain stem stroke, cerebral palsy, locked-in syndrome, among others;
• Sufficient head control and voluntary facial muscle activation (on the basis of clinical evaluation by Dr. Susan Fager and her team) to use the proposed wearable EMG/IMU sensor for the purposes of this study;
• Evidence of at least partial voluntary head movement in at least 2 degrees of freedom (Individual differences in providing controlled movements of the head in various degrees of freedom due to their disease or trauma is not only acceptable but desirable);
• Sufficient stamina and developmental maturity (on the basis of clinical evaluation by Dr. Susan Fager) to attend to the approximately 1-hour protocol outlined in Aims 1 and 3 without excess fatigue or distraction;
• Availability for at least 3-4 testing sessions over the study period;
• No medical or safety restrictions of active head and neck movement (as determined by Dr. Susan Fager in consultation with her clinical team);
• Clinical evidence of preserved cognition by a score of 0 or 1 on NIHSS Consciousness and Communication item;
• Ability to voluntarily blink eyes or raise eyebrows on command.

Exclusion Criteria:

Control Subjects

• Non-English speaker;
• Inability to follow simple instructions in English;
• Restricted ROM of the head or neck;
• Pain with head movement
• Medical history of cardiac or respiratory complications, or disorders that would place the subject at risk for conducting the different motor activities;
• Skin disorders that result in open lesions or hyper-sensitive/fragile skin on the forehead, preventing the use of medical-grade adhesive tapes to secure the sensors to the skin;
• Unable to provide informed consent in English.

Subjects with SPI

• Non-English speaker;
• Inability to follow simple instructions in English;
• Medical history of musculoskeletal conditions (arthritis, spondylosis, etc.) that severely limit head movement or causes pain on head movement;
• Restricted active or passive rotation of head and neck resulting from unstable vertebral, spinal cord, or nerve roots that places the subject at risk;
• Medical history of cardiac or respiratory complications, or similar disorders that would severely reduce stamina and/or place the subject at risk for conducting the different motor activities;
• Skin disorders that result in open lesions or hyper-sensitive/fragile skin on the forehead, preventing the use of medical-grade adhesive tapes to secure the sensors to the skin;
• Unable to provide informed consent in English.

Contacts and Locations

Locations

United States, Massachusetts

Altec Inc.

Natick, Massachusetts, United States, 01760

United States, Nebraska

Madonna Rehabilitation Hospital Institute for Rehabilitation Science and Engineering

Lincoln, Nebraska, United States, 68506

Sponsors and Collaborators

Altec Inc.

Madonna Rehabilitation Hospital

Investigators

• Principal Investigator: Paola Contessa, PhD; Altec Inc.

  Study Documents (Full-Text)

Documents provided by Altec Inc.:

Study Protocol and Statistical Analysis Plan  [PDF] September 29, 2021

More Information

• Responsible Party: Altec Inc.
• ClinicalTrials.gov Identifier: NCT04247828
• Other Study ID Numbers: AAC Phase I
• First Posted: January 30, 2020
• Results First Posted: April 6, 2022
• Last Update Posted: April 6, 2022
• Last Verified: February 2022

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: Yes
• Plan Description: De-identified individual participant data for all primary and secondary outcome measures will be made available.
• Supporting Materials: Study Protocol
• Time Frame: Data will be made available within 6 months of study completion.
• Access Criteria: Data access request will be made through conferencing.

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Altec Inc.:

Communication; Severe Physical Impairments; Spinal Cord Injury

Additional relevant MeSH terms:

Communication Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Neurodevelopmental Disorders; Mental Disorders